Surgical treatment of patients with infective endocarditis: changes in temporal use, patient characteristics, and mortality-a nationwide study

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Andreas Dalsgaard Jensen, University of Copenhagen
  • ,
  • Lauge Østergaard, University of Copenhagen
  • ,
  • Jeppe K Petersen, University of Copenhagen
  • ,
  • Peter Graversen, University of Copenhagen
  • ,
  • Jawad H Butt, University of Copenhagen
  • ,
  • Henning Bundgaard, University of Copenhagen
  • ,
  • Claus Moser, University of Copenhagen
  • ,
  • Morten H Smerup, University of Copenhagen
  • ,
  • Ivy S Modrau
  • Kasper Iversen, University of Copenhagen
  • ,
  • Niels E Bruun, University of Copenhagen
  • ,
  • Christian Torp-Pedersen, Aalborg University, University of Copenhagen
  • ,
  • Gunnar Gislason, University of Copenhagen
  • ,
  • Andrew Wang, Duke University
  • ,
  • Sigurdur Ragnarsson, Lund University
  • ,
  • Jonas A Povlsen
  • Lars Køber, University of Copenhagen
  • ,
  • Emil L Fosbøl, University of Copenhagen

BACKGROUND: Valve surgery guidelines for infective endocarditis (IE) are unchanged over decades and nationwide data about the use of valve surgery do not exist.

METHODS: We included patients with first-time IE (1999-2018) using Danish nationwide registries. Proportions of valve surgery were reported for calendar periods (1999-2003, 2004-2008, 2009-2013, 2014-2018). Comparing calendar periods in multivariable analyses, we computed likelihoods of valve surgery with logistic regression and rates of 30 day postoperative mortality with Cox regression.

RESULTS: We included 8804 patients with first-time IE; 1981 (22.5%) underwent surgery during admission, decreasing by calendar periods (N = 360 [24.4%], N = 483 [24.0%], N = 553 [23.5%], N = 585 [19.7%], P = < 0.001 for trend). For patients undergoing valve surgery, median age increased from 59.7 to 66.9 years (P ≤ 0.001) and the proportion of males increased from 67.8% to 72.6% (P = 0.008) from 1999-2003 to 2014-2018. Compared with 1999-2003, associated likelihoods of valve surgery were: Odds ratio (OR) = 1.14 (95% CI: 0.96-1.35), OR = 1.20 (95% CI: 1.02-1.42), and OR = 1.10 (95% CI: 0.93-1.29) in 2004-2008, 2009-2013, and 2014-2018, respectively. 30 day postoperative mortalities were: 12.7%, 12.8%, 6.9%, and 9.7% by calendar periods. Compared with 1999-2003, associated mortality rates were: Hazard ratio (HR) = 0.96 (95% CI: 0.65-1.41), HR = 0.43 (95% CI: 0.28-0.67), and HR = 0.55 (95% CI 0.37-0.83) in 2004-2008, 2009-2013, and 2014-2018, respectively.

CONCLUSIONS: On a nationwide scale, 22.5% of patients with IE underwent valve surgery. Patient characteristics changed considerably and use of valve surgery decreased over time. The adjusted likelihood of valve surgery was similar between calendar periods with a trend towards an increase while rates of 30 day postoperative mortality decreased.

Original languageEnglish
Article number338
JournalBMC Cardiovascular Disorders
Volume22
Issue1
Number of pages13
ISSN1471-2261
DOIs
Publication statusPublished - Jul 2022

    Research areas

  • Aged, Endocarditis/diagnosis, Endocarditis, Bacterial/surgery, Heart Valve Prosthesis Implantation/adverse effects, Humans, Male, Middle Aged, Odds Ratio, Proportional Hazards Models, Registries, Epidemiology, Cardiac valve surgery, Infective endocarditis, Temporal trend, REGISTER, MANAGEMENT, RISK, TRENDS, CARDIAC-SURGERY, SPECTRUM, EPIDEMIOLOGY

See relations at Aarhus University Citationformats

ID: 276702716